GRF

3
Grifols S.A.
Stock :BME
: Healthcare
: Drug Manufacturers—General
Miracle Viewer
  18/08/2025 16:30 GMT+2
1.89
12.61441
12.21959
-0.981
0.006
0.012
0.012

Ruota il tuo smartphone per vedere un grafico migliore
Ruota il tuo smartphone per vedere un grafico migliore

Operativity type

LONG
Profit %
96.38 %
Timeframe
H 1
Duration
23
GRF
Sector: Health Technology
Industry: Pharmaceuticals: Major
Employees: 23668

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture.

The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials.

The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use.

The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy.

The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks.

The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties.

The Company operates production facilities in Spain, the United States, Mexico and Australia, among others.

It controls numerous subsidiaries.